Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis.
Schiele MA, Reif A, Lin J, Alpers GW, Andersson E, Andersson G, Arolt V, Bergström J, Carlbring P, Eley TC, Esquivel G, Furmark T, Gerlach AL, Hamm A, Helbig-Lang S, Hudson JL, Lang T, Lester KJ, Lindefors N, Lonsdorf TB, Pauli P, Richter J, Rief W, Roberts S, Rück C, Schruers KRJ, Thiel C, Wittchen HU, Domschke K, Weber H, Lueken U. Schiele MA, et al. Among authors: lang t. Eur Neuropsychopharmacol. 2021 Mar;44:105-120. doi: 10.1016/j.euroneuro.2021.01.004. Epub 2021 Jan 20. Eur Neuropsychopharmacol. 2021. PMID: 33483252
(Don't) panic in the scanner! How panic patients with agoraphobia experience a functional magnetic resonance imaging session.
Lueken U, Muehlhan M, Wittchen HU, Kellermann T, Reinhardt I, Konrad C, Lang T, Wittmann A, Ströhle A, Gerlach AL, Ewert A, Kircher T. Lueken U, et al. Among authors: lang t. Eur Neuropsychopharmacol. 2011 Jul;21(7):516-25. doi: 10.1016/j.euroneuro.2010.12.002. Epub 2011 Jan 26. Eur Neuropsychopharmacol. 2011. PMID: 21269812 Clinical Trial.
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.
Rayner C, Coleman JRI, Purves KL, Hodsoll J, Goldsmith K, Alpers GW, Andersson E, Arolt V, Boberg J, Bögels S, Creswell C, Cooper P, Curtis C, Deckert J, Domschke K, El Alaoui S, Fehm L, Fydrich T, Gerlach AL, Grocholewski A, Hahlweg K, Hamm A, Hedman E, Heiervang ER, Hudson JL, Jöhren P, Keers R, Kircher T, Lang T, Lavebratt C, Lee SH, Lester KJ, Lindefors N, Margraf J, Nauta M, Pané-Farré CA, Pauli P, Rapee RM, Reif A, Rief W, Roberts S, Schalling M, Schneider S, Silverman WK, Ströhle A, Teismann T, Thastum M, Wannemüller A, Weber H, Wittchen HU, Wolf C, Rück C, Breen G, Eley TC. Rayner C, et al. Among authors: lang t. Transl Psychiatry. 2019 May 23;9(1):150. doi: 10.1038/s41398-019-0481-y. Transl Psychiatry. 2019. PMID: 31123309 Free PMC article.
Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia.
Ridderbusch IC, Richter J, Yang Y, Hoefler M, Weber H, Reif A, Hamm A, Pané-Farré CA, Gerlach AL, Stroehle A, Pfleiderer B, Arolt V, Wittchen HU, Gloster A, Lang T, Helbig-Lang S, Fehm L, Pauli P, Kircher T, Lueken U, Straube B. Ridderbusch IC, et al. Among authors: lang t. Eur Neuropsychopharmacol. 2019 Oct;29(10):1138-1151. doi: 10.1016/j.euroneuro.2019.07.133. Epub 2019 Aug 20. Eur Neuropsychopharmacol. 2019. PMID: 31444036 Clinical Trial.
Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
Gloster AT, Wittchen HU, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Höfler M, Arolt V. Gloster AT, et al. Among authors: lang t. J Consult Clin Psychol. 2011 Jun;79(3):406-20. doi: 10.1037/a0023584. J Consult Clin Psychol. 2011. PMID: 21534651 Clinical Trial.
Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
Emmrich A, Beesdo-Baum K, Gloster AT, Knappe S, Höfler M, Arolt V, Deckert J, Gerlach AL, Hamm A, Kircher T, Lang T, Richter J, Ströhle A, Zwanzger P, Wittchen HU. Emmrich A, et al. Among authors: lang t. Psychother Psychosom. 2012;81(3):161-72. doi: 10.1159/000335246. Epub 2012 Mar 3. Psychother Psychosom. 2012. PMID: 22399019 Free article. Clinical Trial.
Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobia.
Cammin-Nowak S, Helbig-Lang S, Lang T, Gloster AT, Fehm L, Gerlach AL, Ströhle A, Deckert J, Kircher T, Hamm AO, Alpers GW, Arolt V, Wittchen HU. Cammin-Nowak S, et al. Among authors: lang t. J Clin Psychol. 2013 Jun;69(6):616-29. doi: 10.1002/jclp.21975. Epub 2013 Mar 15. J Clin Psychol. 2013. PMID: 23504641 Clinical Trial.
The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: associations to symptom severity, treatment course, and outcome.
Helbig-Lang S, Richter J, Lang T, Gerlach AL, Fehm L, Alpers GW, Ströhle A, Kircher T, Deckert J, Gloster AT, Wittchen HU. Helbig-Lang S, et al. Among authors: lang t. J Anxiety Disord. 2014 Dec;28(8):836-44. doi: 10.1016/j.janxdis.2014.09.010. Epub 2014 Oct 5. J Anxiety Disord. 2014. PMID: 25445073 Clinical Trial.
1,525 results